Lung - Cancer
This Society of Thoracic Surgeons Expert Consensus Documents provides updated, multidisciplinary guidance on the multimodal management of pleural mesothelioma (PM). The expert panel emphasizes that surgical resection should only be performed as part of a...
This article summarizes the surgical treatment of Pope Leo XIV, who was recently diagnosed with lung adenocarcinoma. Surgeons performed a uniportal video-assisted thoracoscopic surgery (VATS) lobectomy. The surgery team reported...
This video presents the authors’ standardized technique for multiportal robotic-assisted left pneumonectomy after neoadjuvant chemoimmunotherapy, using a five-step hilar dissection based on the principles of the French lobectomy approach. In...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Bart P. van Putte, a cardiothoracic surgeon at the St. Antonius Hospital in Nieuwegein, Netherlands, and the Amsterdam University...
This prospective European Society of Thoracic Surgeons (ESTS) Drainology Collaborative registry study examined chest-drain practice after pulmonary resection in 3,348 patients across 21 international centers, 88 percent of whom underwent...
As a part of Session 1 of the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer, Hisao Asamura presented on changes to SLR for lung cancer...
After an introduction giving an overview of the conference by Dominique Gossot, Xavier-Benoit D’Journo, and Isabelle Opitz, the 4th International Conference for Sublobar Resections and Evolving Techniques for Lung Cancer...
Sleeve lobectomy is preferred to pneumonectomy for centrally located lung tumors. To report on surgical outcomes of this procedure, The European Society of Thoracic Surgeons database was searched between 2007...
Since time to surgery for lung cancer is not well established, researchers aimed to assess whether time to surgery from diagnosis correlates with outcomes like unplanned return to care, mortality,...
The FDA has approved the drug Cytalux for use in lung surgery. The drug, also known as pafolacianine, binds to lung cancer cells to make them glow under infrared light....
Researchers have been awarded a grant to fund cancer vaccine research, including the development of an mRNA vaccine that would target precancerous lung lesions. Eventually, researchers hope to develop an...
This study aimed to establish risk factors for venous thromboembolism (VTE), a significant cause of mortality in lung cancer surgical patients. Unlike in surgical specialties that have adopted postdischarge VTE...
Surgical management for potentially resectable stage IIIA-N2 non-small cell lung cancer (NSCLC) is controversial. In this study, researchers examined outcomes of a well-selected surgical cohort of postinduction IIIA-N2 NSCLC patients...





